2 news items
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
CLNN
28 May 24
potential drug effects on survival and disease progression with the use of natural history and control clinical trial database comparators. Biomarker data
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
CLNN
13 Mar 24
Natural History Consortium. The EAP dataset was comprised of 256 participants with ALS of which 220 EAP participants had all baseline values available
- Prev
- 1
- Next